INFLUENZA
Clinical trials for INFLUENZA explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA trials appear
Sign up with your email to follow new studies for INFLUENZA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New flu shot for seniors passes early safety check
⭐️ VACCINE ⭐️ OngoingThis early-stage study tested whether a new flu vaccine with an added booster (adjuvant) is safe for people 65 and older. 80 volunteers received the vaccine and were monitored for side effects over a year. The goal was to check for any immediate or long-term reactions, not yet to…
Matched conditions: INFLUENZA
Phase: PHASE1 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 00:53 UTC
-
Nasal spray flu vaccine study seeks kids for immune response check
⭐️ VACCINE ⭐️ ENROLLING_BY_INVITATIONThis study looks at how well a nasal spray flu vaccine works in children aged 3 to 17. Researchers will measure specific antibodies in the nose to see if the vaccine boosts immunity. The goal is to understand the body's immune response after getting the spray.
Matched conditions: INFLUENZA
Phase: PHASE4 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 00:47 UTC
-
New flu shot for seniors passes early safety check
⭐️ VACCINE ⭐️ OngoingThis early-stage study tested whether a new flu vaccine with an added booster (adjuvant) is safe for adults aged 65 and older. About 80 participants received the vaccine and were monitored for side effects over a year. The goal was to check for any immediate or long-term safety c…
Matched conditions: INFLUENZA
Phase: PHASE1 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 00:46 UTC
-
Could a stronger flu shot better protect transplant patients?
⭐️ VACCINE ⭐️ OngoingThis study tests whether a high-dose flu vaccine works better than the standard dose for adults who have recently had a kidney, heart, or liver transplant. About 400 participants, all within 1 to 11 months after transplant, will receive either two high-dose shots, two standard-do…
Matched conditions: INFLUENZA
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:57 UTC
-
Vietnam tests chat groups and posters to get seniors vaccinated against flu
⭐️ VACCINE ⭐️ OngoingThis study tests whether community-based communication—like counseling, social media messages, and educational materials—can increase flu vaccination rates among people over 65 in Vietnam. About 1,200 elderly participants from different neighborhoods will be randomly assigned to …
Matched conditions: INFLUENZA
Phase: NA • Sponsor: Can Tho University of Medicine and Pharmacy • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:56 UTC
-
New flu vaccine shows promise in large trial
⭐️ VACCINE ⭐️ OngoingThis study tests a single shot of an experimental flu vaccine called OVX836 in about 2,850 healthy adults aged 18 to 59. The goal is to see if it prevents flu better than a placebo and to check its safety. Participants are socially active people who are likely to be exposed to th…
Matched conditions: INFLUENZA
Phase: PHASE2 • Sponsor: Osivax • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:53 UTC
-
New mRNA flu shot enters human testing
⭐️ VACCINE ⭐️ OngoingThis early-stage study is testing a new mRNA-based flu vaccine in about 50 healthy adults aged 18 to 49. Participants will receive either the experimental vaccine at one of three dose levels or a licensed flu shot for comparison. The main goal is to see if the vaccine is safe and…
Matched conditions: INFLUENZA
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:49 UTC
-
Military study to find best flu shot among three options
⭐️ VACCINE ⭐️ OngoingThis study enrolled over 15,000 military members to compare three different flu vaccines: cell-based, recombinant, and egg-based. Participants were randomly assigned to one of the three vaccines over four flu seasons. The main goal was to see which vaccine best prevents lab-confi…
Matched conditions: INFLUENZA
Phase: PHASE4 • Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine • Aim: ⭐️ VACCINE ⭐️
Last updated May 08, 2026 12:01 UTC
-
Nasal spray flu vaccine study aims to boost protection in teens
⭐️ VACCINE ⭐️ OngoingThis study looks at how well a nasal spray flu vaccine works in 60 healthy teenagers aged 14 to 17. Researchers will measure immune responses in the nose and blood before and after vaccination. The goal is to understand how the vaccine protects against the flu and to explore link…
Matched conditions: INFLUENZA
Phase: PHASE4 • Sponsor: Jiangsu Province Centers for Disease Control and Prevention • Aim: ⭐️ VACCINE ⭐️
Last updated May 06, 2026 16:14 UTC
-
Can a smart stethoscope sniff out COVID, flu, and RSV?
Diagnosis OngoingThis study tests two new devices that use sound waves to detect COVID-19, flu, and RSV without needles or swabs. About 300 adults will have a quick, painless scan and answer a symptom questionnaire. The goal is to see if these tools can accurately identify infections, even in peo…
Matched conditions: INFLUENZA
Sponsor: The Geneva Foundation • Aim: Diagnosis
Last updated May 12, 2026 13:42 UTC
-
Could 5 days of tamiflu be enough to stop flu in hospitals?
Prevention OngoingThis study tests whether taking the flu medicine oseltamivir (Tamiflu) for 5 days works just as well as taking it for 10 days to prevent the flu in hospital patients who have been exposed. About 200 adults with risk factors for flu complications will take part. If 5 days is enoug…
Matched conditions: INFLUENZA
Phase: PHASE3 • Sponsor: University Medical Centre Ljubljana • Aim: Prevention
Last updated May 13, 2026 16:02 UTC
-
New One-Dose flu prevention shot could protect High-Risk groups for months
Prevention OngoingThis study tests a single-dose shot called CD388 to see if it can prevent the flu in people aged 12 and older who are at higher risk for serious flu complications. About 7,500 participants will receive either CD388 or a placebo and be monitored for up to 24 weeks. The goal is to …
Matched conditions: INFLUENZA
Phase: PHASE3 • Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Prevention
Last updated May 11, 2026 20:51 UTC
-
Text nudges aim to boost flu vaccination rates
Prevention OngoingThis study tests different text message reminders to see which ones work best at getting people to get their flu vaccine. About 100,000 patients who haven't had their flu shot yet will receive a reminder text before a clinic visit. The goal is to find simple, effective ways to in…
Matched conditions: INFLUENZA
Phase: NA • Sponsor: Kaiser Permanente • Aim: Prevention
Last updated May 08, 2026 12:03 UTC
-
New flu pill TRX-100 enters early human testing
Symptom relief OngoingThis early-stage study tests different doses of an experimental oral drug called TRX-100 in people with mild to moderate influenza. About 105 participants will receive the study drug plus standard flu care. The main goals are to check safety and find the best dose, while also tra…
Matched conditions: INFLUENZA
Phase: PHASE2 • Sponsor: Traws Pharma, Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:40 UTC
-
Baby's first flu: a lifelong immune blueprint?
Knowledge-focused OngoingThis study follows 1500 healthy infants from birth to age 4 to understand how their first exposure to influenza—either through vaccination or natural infection—affects their immune system's response to future flu exposures. Pregnant mothers are enrolled before delivery, and their…
Matched conditions: INFLUENZA
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated May 17, 2026 00:53 UTC
-
Gut check: could your diet determine flu shot success?
Knowledge-focused OngoingThis study looks at whether the bacteria in your gut and what you eat can influence how well your body responds to the flu vaccine. Researchers will collect stool samples, blood samples, and dietary information from 74 adults to find connections. No new treatment is being tested—…
Matched conditions: INFLUENZA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 00:52 UTC
-
New study tracks lingering symptoms of COVID-19 and flu
Knowledge-focused OngoingThis study follows about 1,000 adults with confirmed COVID-19 or flu to see how their symptoms and quality of life change over six months. Participants fill out surveys about their health, daily activities, and vaccine history. No treatment is given; the goal is to better underst…
Matched conditions: INFLUENZA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 17, 2026 00:52 UTC
-
500 kids help unlock secrets of flu, RSV, and COVID spread
Knowledge-focused OngoingThis study follows 500 children under 18 who tested positive for flu, RSV, or COVID-19. Researchers track how long they stay contagious and how the viruses spread to family members and classmates. The goal is to provide better data for public health decisions during respiratory v…
Matched conditions: INFLUENZA
Sponsor: The Hospital for Sick Children • Aim: Knowledge-focused
Last updated May 17, 2026 00:45 UTC
-
Fiber fuel: could your diet boost flu vaccine power?
Knowledge-focused OngoingThis study looks at whether eating more fiber can change the bacteria in your gut and improve how well the flu vaccine works. About 31 healthy adults will follow a special diet before getting their flu shot. Researchers will check if the diet is easy to follow and if it leads to …
Matched conditions: INFLUENZA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC
-
Can a smell test spot COVID? new study investigates
Knowledge-focused OngoingThis study involves 1,000 participants who use special smell cards at home to measure their sense of smell. The goal is to see if these tests can reliably detect smell loss caused by COVID-19 and track recovery over time. Results may help design future treatments for smell proble…
Matched conditions: INFLUENZA
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC